Please login to the form below
Coronavirus
This page shows the latest Coronavirus news and features for those working in and with pharma, biotech and healthcare.
Pfizer/BioNTech’s Omicron-adapted booster approved by FDA for young children
The companies have also submitted an application to the EMA for this age group
Latest news
-
Pfizer/BioNTech submit FDA application for Omicron-adapted booster for young children
The vaccine is already authorised as the third of a three-dose primary series in this age group
-
Gilead reports positive real-world evidence for COVID-19 treatment Veklury
A study of more than 500,000 hospitalised patients showed a reduction in mortality risk
-
Merck and Ridgeback’s COVID-19 pill fails to prevent infection within households
Lagevrio is already approved to treat certain patients with COVID-19 in several markets
-
GSK and Vir Biotech amend COVID-19 research partnership
Our collaborative efforts have also yielded a compelling portfolio of next-generation coronavirus solutions that, given Vir’s infectious disease expertise, we plan to pursue independently.”.
-
Eiger BioPharmaceuticals reports positive phase 3 results for COVID-19 treatment
Peginterferon lambda showed a 51% reduction in hospitalisations or emergency room visits
More from news
Approximately 657 fully matching, plus 32 partially matching documents found.
Latest Intelligence
-
AI: powering healthcare, empowering patients Physician perceptions of AI and the future of pharma
In the face of the coronavirus, innovative technologies such as artificial intelligence (AI) and machine learning (ML) have proven vital for the protection and promotion of public health.
-
Lessons from a pandemic – holistic strategy in the time of coronavirus
COVID-19 has delivered a scenario where developing the strategy for any brand is a challenge
-
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
While the existence of the new coronavirus was not known until January 2020, AMR is a threat we have known about for years.
-
Diversity and inclusion in clinical trials
Why are so many talking about it now? The answer probably lies at the intersection of three different incidents: the coronavirus pandemic which has pushed the industry in so many different ... The coronavirus pandemic placed clinical research on the
-
The new reality of building a corporate brand in pharma
Until the likes of Pfizer, AstraZeneca and Moderna started to have their coronavirus vaccines approved, the companies behind the medicines were rarely recognised by the public.
More from intelligence
Approximately 3 fully matching, plus 36 partially matching documents found.
Latest from PMHub
-
Diabetes management – should there be a 'one-size fit all' approach?
While many of these courses, including DAFNE moved online following the coronavirus pandemic, the DAFNE online course still incorporates a mix of online learning and remote group sessions facilitated by specialist
-
How can Pharma help HCPs face Dr. Google?
People rely on online searches for much of their knowledge gathering and as screen life has become an even bigger part of people’s lives during coronavirus – adults spent an average
-
Lesson Learned from the Pandemic
Tom Hsu, VP of Specialty Medicine at Bayer Canada, talks about how he got to where he is today and his experience working for Bayer in China and how that compares to the work he is doing now in Canada. He also discusses the lessons learned from the
-
WHITE PAPER: Gender inequality—how COVID-19 impacted women
Last updated September 3 2021. Accessed September 14 2021. 14. Coronavirus Crossroads: Equal Pay Day 2020 Report. ... Published 2021. Accessed September 2021. 26. Harapan H et al. Coronavirus disease 2019 (COVID-19): A literature review.
-
Black community representation in clinical trials
4]. COVID-19. Coronavirus (COVID-19) has had a devastating impact on countries around the world. ... 6] Office for National Statistics (May, 2020). Coronavirus (COVID-19) related deaths by ethnic group, England and Wales: 2 March 2020 to 10 April 2020.
More from PMHub
Approximately 14 fully matching, plus 60 partially matching documents found.
Subscribe to our email news alerts
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Technical Sales Representative
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- 2023 PM Society Awards – winners announced
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- LEO Pharma enters clinical trial partnership with ICON
- MHRA to introduce new UK clinical trials framework
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Inizio appoints Stefanie Christmas as global head of DE&I
- Rare diseases: not so rare after all
- Sanofi/Regeneron’s Dupixent shows promise in atopic hand and foot dermatitis
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- MHRA to introduce new UK clinical trials framework
- A relentless commitment to neuroscience
- Sanofi to acquire Provention Bio in deal worth $2.9bn
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
PMHub
Syneos Health®
Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
